Delivering a shared agenda for the UK’, it explored how to ensure NHS patients benefit from the latest medicines and vaccines ...

The Association of the British Pharmaceutical Industry (ABPI) has added five new patient organisation figures to its patient advisory council, set up to provide patient perspective on its ...

Drug industry’s self-regulatory body criticises Theramex, producer of Evorel and Intrarosa, for ‘alarming’ breaches ...

Health secretary’s ‘power grab’ to override Nice comes amid growing concern move may be illegal and benefit big pharma ...

Joint initiatives risk prioritising commercial interests over patient benefit, write Margaret McCartney and James Larkin In ...

In good news for UK life sciences investment, two companies have made pledges to build new facilities, totaling nearly half a ...

US President Donald Trump’s long obsession with pharmaceuticals and tariffs forced the UK into a controversial drug deal, ...

Theramex has opted out of the U.K.’s self-regulatory program for pharma ma | Theramex has opted out of the U.K.’s ...

Pharma teams often blame compliance when digital projects slow down. In reality, the bigger issue is usually weaker ownership, unclear review models and content structures that were never designed for ...

UK government drives forward its 150-day clinical trial target: United Kingdom Friday, April 17, 2026, 09:00 Hrs [IST] NHS patients will be able to access life-changing new treatm ...

The MHRA continues to speed up access to medicines for patients, increase efficiency of regulation and help to attract innovation and investment in ...

Finance For Non-Financial Leaders In The UK And Global Pharmaceutical Industry. Enhance financial literacy in the pharmaceutical sector by equipping non-financial leaders with skills to interpret ...